These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1134 related articles for article (PubMed ID: 25499150)
41. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia. Wong JJ; Lau KA; Pinello N; Rasko JE Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401 [TBL] [Abstract][Full Text] [Related]
42. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. Malcovati L; Papaemmanuil E; Ambaglio I; Elena C; Gallì A; Della Porta MG; Travaglino E; Pietra D; Pascutto C; Ubezio M; Bono E; Da Vià MC; Brisci A; Bruno F; Cremonesi L; Ferrari M; Boveri E; Invernizzi R; Campbell PJ; Cazzola M Blood; 2014 Aug; 124(9):1513-21. PubMed ID: 24970933 [TBL] [Abstract][Full Text] [Related]
43. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275 [TBL] [Abstract][Full Text] [Related]
44. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies. McDevitt MA Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms underlying the heterogeneity of myelodysplastic syndromes. Dussiau C; Fontenay M Exp Hematol; 2018 Feb; 58():17-26. PubMed ID: 29175473 [TBL] [Abstract][Full Text] [Related]
46. A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations. Li X; Xu F; Wu LY; Zhao YS; Guo J; He Q; Zhang Z; Chang CK; Wu D Sci Rep; 2020 Jan; 10(1):826. PubMed ID: 31964915 [TBL] [Abstract][Full Text] [Related]
47. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Thol F; Kade S; Schlarmann C; Löffeld P; Morgan M; Krauter J; Wlodarski MW; Kölking B; Wichmann M; Görlich K; Göhring G; Bug G; Ottmann O; Niemeyer CM; Hofmann WK; Schlegelberger B; Ganser A; Heuser M Blood; 2012 Apr; 119(15):3578-84. PubMed ID: 22389253 [TBL] [Abstract][Full Text] [Related]
48. Genetics of myelodysplastic syndromes: new insights. Graubert T; Walter MJ Hematology Am Soc Hematol Educ Program; 2011; 2011():543-9. PubMed ID: 22160087 [TBL] [Abstract][Full Text] [Related]
49. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia. Man N; Mas G; Karl DL; Sun J; Liu F; Yang Q; Torres-Martin M; Itonaga H; Martinez C; Chen S; Xu Y; Duffort S; Hamard PJ; Chen C; Zucconi BE; Cimmino L; Yang FC; Xu M; Cole PA; Figueroa ME; Nimer SD JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622806 [TBL] [Abstract][Full Text] [Related]
50. Epigenetics in myelodysplastic syndromes. Heuser M; Yun H; Thol F Semin Cancer Biol; 2018 Aug; 51():170-179. PubMed ID: 28778402 [TBL] [Abstract][Full Text] [Related]
51. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659 [TBL] [Abstract][Full Text] [Related]
52. Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias. Itzykson R; Kosmider O; Cluzeau T; Mansat-De Mas V; Dreyfus F; Beyne-Rauzy O; Quesnel B; Vey N; Gelsi-Boyer V; Raynaud S; Preudhomme C; Adès L; Fenaux P; Fontenay M; Leukemia; 2011 Jul; 25(7):1147-52. PubMed ID: 21494260 [TBL] [Abstract][Full Text] [Related]
57. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes. Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277 [TBL] [Abstract][Full Text] [Related]
58. Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Babushok DV; Bessler M Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730 [TBL] [Abstract][Full Text] [Related]